Differences

This shows you the differences between two versions of the page.

--- martin_lavoie [2022/04/21 23:23]
liam
+++ martin_lavoie [2022/04/22 00:16] (current)
liam
@@ Line 6: / Line 6: @@
 ===== Career and Affiliations =====
+==== Alberta Health Services ====
+Lavoie was Medical Officer of Health for the [[David Thompson Health Region]] (DTHR) from 2002-2008. The DTHR reorganized into [[public_health_agencies:canada:Alberta Health Services]] in 2008, where Lavoie continued into his new role as Senior Provincial Medical Officer of Health, and eventually Deputy Chief Medical Officer of Health until 2017.((//Martin Lavoie · Dep Chief Med Officer of Hlth · Health.// OpenGovCA. Retrieved April 21, 2022, from https://opengovca.com/alberta-employee/martin-lavoie)) ((Tuckwell, J., & May, H. (2009). //Province appoints senior provincial medical officers of health.// Alberta Health and Wellness. https://web.archive.org/web/20220421214519/https://www.alberta.ca/release.cfm?xID=26884be32f88e-b21f-0d6c-a529f625278f75b9))
+While at AHS, Lavoie advocated for people to get the [[influenza vaccine|influenza vaccines]].((Luedee, T., & Ziegler, C. (2015, December 10). //Spread joy, not germs: stay healthy this holiday season.// Alberta Health Services. https://www.albertahealthservices.ca/news/releases/2015/Page12879.aspx))
+==== University of Alberta ====
+Lavoie is an Assistant Clinical Professor in the Department of Medicine at the [[University of Alberta]].
+==== Fraser Health Authority ====
+Lavoie worked for the [[public_health_agencies:Canada:british_columbia:Fraser Health Authority]] from August 2017 to July 2020. He started as the Executive Medical Director/Medical Officer of Health, then moved to Interim VP of Population Health and Chief Medical Officer of Health, then fully taking that position.((//Martin Lavoie.// LinkedIn. Retrieved April 21, 2022, from https://www.linkedin.com/in/martin-lavoie-9200a949/)) ((Lavoie, M. (2020, April 17). //Letter from Fraser Health Chief Medical Health Officer Dr Martin Lavoie.// Fraser Health. https://www.fraserhealth.ca/news/2020/Apr/letter-from-fraser-health-chief-medical-health-officer-dr-martin-lavoie))
+==== Government of British Columbia ====
+Lavoie is a Deputy Provincial Health Officer for the [[Government of British Columbia]], serving under Dr. [[Bonnie Henry]] at the [[BC Ministry of Health]].((//Biographies.// (2018). Province of British Columbia. https://archive.ph/PMpwF)) He began in this position in July 2020.((The Tablet. (2021, July 16). //BCPhA 2021 Conference Highlights: Dr. Martin Lavoie.// BC Pharmacy Association. https://archive.ph/uwIPw))
 ==== Public Health Agency of Canada ====
@@ Line 11: / Line 29: @@
 Lavoie is a liaison representative for the [[Council of Chief Medical Officers of Health]] on the [[National Advisory Committee on Immunization]] (NACI), the body responsible for recommending the approval of [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))
-==== Government of British Columbia ====
+===== Research =====
+==== Influenza ====
+Lavoie has participated in research on [[H1N1]] influenza, including in collaboration with the [[National Microbiology Laboratory]] under the [[Public Health Agency of Canada]] and the [[Center for Disease Control and prevention|Centers for Disease Control and Prevention]] (CDC) in the United States.((Howden, K. J., Brockhoff, E. J., Caya, F. D., McLeod, L. J., Lavoie, M., Ing, J. D., Bystrom, J. M., Alexandersen, S., Pasick, J. M., Berhane, Y., Morrison, M. E., Keenliside, J. M., Laurendeau, S., & Rohonczy, E. B. (2009). //An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm.// The Canadian veterinary journal = La revue veterinaire canadienne, 50(11), 1153–1161.))
+==== Funding ====
+Lavoie has participated in research funded by the [[Alberta Innovates]] Health Solutions Team Collaborative Innovation Opportunity. AI is partnered with [[pharmaceutical_companies:Pfizer]].((//2020/21 Annual Report.// (2021, August). Alberta Innovates. https://albertainnovates.ca/app/uploads/2021/08/AI-2020-21-ANNUAL-REPORT_WEB-1.pdf)) Further funding has come from the [[Alberta Children's Hospital Research Institute]], the [[Women and Children's Health Research Institute]], and the [[Alberta Children's Hospital Foundation]].
+===== Presentations =====
-Lavoie is a Deputy Provincial Health Officer for the [[Government of British Columbia]], serving under Dr. [[Bonnie Henry]] at the [[BC Ministry of Health]].
+Lavoie was a presenter at the [[British Columbia Pharmacy Association]] (BCPhA) 2021 Conference, where he discussed [[COVID-19 vaccines]]. The conference is sponsored by [[pharmaceutical_companies:Abbott]], [[pharmaceutical_companies:AbbVie]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Janssen]], [[London Drugs]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Pharmascience]], [[pharmaceutical_companies:Sandoz]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Seqirus]], [[pharmaceutical_companies:Takeda]], [[pharmaceutical_companies:Trudell]], and [[pharmaceutical_companies:Unipharm]].((//Sponsors.// BC Pharmacy Association. Retrieved April 21, 2022, from https://archive.ph/IYo7e))